As expected, a decrease in Ki67 had been found in almost all molecular subtypes after NAC (the triple-negative type BCs had a borderline significant), which was consistent with previous research [ 18 ].
← all excerpts
Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.
1
—
—